Psychedelic Medicine

CBD is now an FDA-approved medicine, but there has been very little study into how food affects the cannabis-derived compound’s absorption. A valuable new study has strikingly found that CBD absorption is significantly increased when it is consumed alongside high-fat foods.

Denver-based company Sträva revealed it has begun developing tea and coffee products infused with microdoses of psilocybin. Following the recent decriminalization measure passed in the city of Denver, Sträva suggests it could reach the market with psilocybin coffee within two years.

A compelling study has revealed how a mammalian brain can produce an incredibly powerful hallucinogen called DMT. The research shows the psychedelic is endogenously produced in a number of brain regions, including the visual cortex, and spikes in concentrations following an induced cardiac arrest.

A fascinating new study from scientists at the University of Chicago is offering the very first placebo-controlled clinical research testing the mood-altering, physiological and behavioral effects of tiny LSD microdoses.

Following last month’s historic ballot initiative in Denver that decriminalized psilocybin magic mushrooms, Oakland City Council has passed a resolution decriminalizing the adult use of all entheogenic plants, including magic mushrooms, cactus and any natural materials used to produce ayahuasca.

​A new study is suggesting a great number of individuals are self-treating problematic alcohol consumption with strong doses of LSD or psilocybin. The research rekindles interest in a strong vein of study from the 1950s and 1960s into LSD and alcoholism.

After a tense 24 hours of vote counting it seems a Denver city initiative to essentially decriminalize personal use and possession of psilocybin magic mushrooms has been passed. With a margin of less than 2,000 votes Denver becomes the first city in the United States pass such a measure.

A thousand-year-old pouch in Bolivia has revealed traces of several psychoactive compounds, indicating not only some of the earliest archeological evidence of ayahuasca use but also other intoxicants. The find suggests significant plant knowledge and a broad ancient plant trading network.

The world's first formal facility dedicated to the study of psychedelic​s has been launched at Imperial College London. The Centre for Psychedelics Research​ is not the only major psychedelic research group in the world, but is the first to be officially integrated into a large academic institution.

A study led by scientists at Yale University has described the promising early-stage results of a new drug designed to mimic the rapid antidepressant effects of ketamine, but without that drug’s dissociative psychoactive qualities. The experimental drug is currently in early phases of human testing.

Following the FDA’s approval of a ketamine-inspired nasal spray for treatment-resistant depression, new research is offering provocative insights into how the drug exerts such a rapid anti-depressant effect and points to new pathways for research into alternative drugs to treat depression.

A new study is helping clarify what is going on in our brains when we are hallucinating. To do this, researchers from the University of Oregon dosed mice with a powerful psychedelic drug and with unprecedented detail ​zoomed in on how the animal’s brains subsequently generated visual hallucinations.